The current status of renal cell carcinoma and prostate carcinoma grading

by Brett Delahunt, Lars Egevad, John Yaxley, Hemamali Samaratunga

Emerging entities of renal cell neoplasia

by Brett Delahunt, John N. Eble, Lars Egevad, John Yaxley, Michelle Thunders, Hemamali Samaratunga
Published 2019-04-01

Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation

by Matthew J. Roberts, Renee S. Richards, Clement W.K. Chow, Marion Buck, John Yaxley, Martin F. Lavin, Horst Joachim Schirra, Robert A. Gardiner
Published 2017-12-01

Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers

by Matthew J. Roberts, Renee S. Richards, Clement W.K. Chow, Suhail A.R. Doi, Horst Joachim Schirra, Marion Buck, Hemamali Samaratunga, Joanna Perry-Keene, Diane Payton, John Yaxley, Martin F. Lavin, Robert A. Gardiner
Published 2016-09-01

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.

by Jyotsna Batra, Felicity Lose, Tracy O'Mara, Louise Marquart, Carson Stephens, Kimberly Alexander, Srilakshmi Srinivasan, Rosalind A Eeles, Douglas F Easton, Ali Amin Al Olama, Zsofia Kote-Jarai, Michelle Guy, Kenneth Muir, Artitaya Lophatananon, Aneela A Rahman, David E Neal, Freddie C Hamdy, Jenny L Donovan, Suzanne Chambers, Robert A Gardiner, Joanne Aitken, John Yaxley, Mary-Anne Kedda, Judith A Clements, Amanda B Spurdle
Published 2011-01-01